Hepatitis C  >>  pioglitazone  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00189163: Pioglitazone in Hepatitis C

Completed
4
40
US
Pioglitazone, Actos, Placebo Oral Tablet
University of Michigan
Chronic Hepatitis C
12/07
 
NCT00545233: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Completed
4
155
US
peginterferon alfa-2a [Pegasys], Pegasys, ribavirin [Copegus], Copegus, Pioglitazone, Actos
Hoffmann-La Roche
Hepatitis C, Chronic
12/10
12/10
NCT00926614: Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Completed
4
20
US
pioglitazone (Actos), Actos, atorvastatin (Lipitor), Lipitor
Brooke Army Medical Center
Hepatitis c
06/11
12/11
NCT00742326: Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections

Terminated
4
13
US
Pioglitazone, Avandia, Placebo
National Institute of Allergy and Infectious Diseases (NIAID)
HIV, Hepatitis C, Liver Disease, Fatty Liver, Steatosis
01/13
01/13

Download Options